NMDAR1 autoantibodies as potential biomarkers for schizophrenia phenotyping
- PMID: 39300631
- DOI: 10.1016/S2215-0366(24)00282-7
NMDAR1 autoantibodies as potential biomarkers for schizophrenia phenotyping
Conflict of interest statement
We declare no competing interests.
Comment on
-
Clinical symptoms and psychosocial functioning in patients with schizophrenia spectrum disorders testing seropositive for anti-NMDAR antibodies: a case-control comparison with patients testing negative.Lancet Psychiatry. 2024 Oct;11(10):828-838. doi: 10.1016/S2215-0366(24)00249-9. Lancet Psychiatry. 2024. PMID: 39300641
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical